Stocktoria

HERBALIFE LTD. HLF

NYSE · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2004-12-16 · LEI

HERBALIFE LTD. (HLF) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 2.34% (safety: no dividend). FY2025 revenue was $5.0B at a 4.5% net margin.

Chart by TradingView
36/100
Stocktoria Quality Score · grade D
5/9
Piotroski F — financial health
0.63
Altman Z″ — distress risk · distress
1.8%
Dividend yield 5y avg · no dividend
-2.31
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
6 5 7 8 6 6 5 4 7 5 2016201720182019202020212022202320242025
Altman Z″
2.92 3.20 1.32 2.31 1.83 0.87 0.48 -0.38 -0.46 0.63 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$11.69 as of 2026-08-01 · +19.5% 1y
$8.00$19.5252-wk

Beneish M-score: -2.31 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$1.3B
P / E5.7×
Dividend yield 5y avg1.8%
Net margin 5y avg5.3%
Beta0.89
Employees8,500

Analyst price target

$18.33 +56.8% vs last
· 3 analysts
target range $9.00 – $25.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net sold -$2.5M on the open market · 5 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Wholesale Trade · percentile among 112 companies

Piotroski Fstronger than 54%
Net marginstronger than 72%
Revenue growthstronger than 45%

Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.047
Retained earnings / assets-0.208
EBIT / assets0.173
Equity / liabilities-0.156

Sector peers · similar-size Wholesale Trade companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
HLFHERBALIFE LTD.5/90.635.7+0.9%
NUSNU SKIN ENTERPRISES, INC.6/97.361.6-14.3%
COSMCosmos Health Inc.5/9-7.92+19.9%
ZSTKZeroStack Corp.-13.69-0.5%
WGRXWellgistics Health, Inc.2/9+28.7%
NASCCan B Corp1/9
HWHHWH International Inc.3/9

All Wholesale Trade companies →

About HERBALIFE LTD.

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

FAQ

Is HLF financially healthy?

HERBALIFE LTD.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does HLF pay a dividend, and is it safe?

Yes. HERBALIFE LTD. pays a dividend yielding about 2.34% with a None payout ratio, rated “no dividend” for safety.

How profitable is HLF?

In FY2025, HERBALIFE LTD. had a net margin of 4.5%.

Is HLF overvalued or undervalued?

HERBALIFE LTD. trades at about 5.3× trailing earnings — below its 10-year norm (10-year range 2.2×–32.2×, median 17.7×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for HLF?

The average Wall-Street price target for HERBALIFE LTD. is $18.33, about 56.8% above the recent price, from 3 analysts.

Is HLF a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on HERBALIFE LTD.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 5.7×, a dividend yield of 2.34%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.